Wireless sensor networks (WSNs) have become widely popular and are extensively used for various sensor communication applications due to their flexibility and cost effectiveness, especially for applications where localization is a main challenge. Furthermore, the Dv-hop algorithm is a range-free localization algorithm commonly used in WSNs. Despite its simplicity and low hardware requirements, it does suffer from limitations in terms of localization accuracy. In this article, we develop an accurate Deep Learning (DL)-based range-free localization for WSN applications in the Internet of things (IoT). To improve the localization performance, we exploit a deep neural network (DNN) to correct the estimated distance between the unknown nodes (i.e., position-unaware) and the anchor nodes (i.e., position-aware) without burdening the IoT cost. DL needs large training data to yield accurate results, and the DNN is no stranger. The efficacy of machine learning, including DNNs, hinges on access to substantial training data for optimal performance. However, to address this challenge, we propose a solution through the implementation of a Data Augmentation Strategy (DAS). This strategy involves the strategic creation of multiple virtual anchors around the existing real anchors. Consequently, this process generates more training data and significantly increases data size. We prove that DAS can provide the DNNs with sufficient training data, and ultimately making it more feasible for WSNs and the IoT to fully benefit from low-cost DNN-aided localization. The simulation results indicate that the accuracy of the proposed (Dv-hop with DNN correction) surpasses that of Dv-hop.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11154441 | PMC |
http://dx.doi.org/10.3390/s24020430 | DOI Listing |
Endocrinol Diabetes Metab
January 2025
Department of Endocrinology and Metabolism, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Objective: This study investigates the relationship between the albumin-to-creatinine ratio and diabetic retinopathy (DR) in US adults using NHANES data from 2009 to 2016. This study assesses the predictive efficacy of the urinary serum albumin-to-creatinine ratio (UACR/SACR Ratio) against traditional biomarkers such as the serum albumin-to-creatinine ratio (SACR) and urinary albumin-to-creatinine ratio (UACR) for evaluating DR risk. Additionally, the study explores the potential of these biomarkers, both individually and in combination with HbA1c, for early detection and risk stratification of DR.
View Article and Find Full Text PDFDrugs
January 2025
Lysosomal Storage Disorders Unit, Royal Free London NHS Foundation Trust, University College London, London, NW3 2QG, UK.
Lysosomal storage disorders (LSDs) are rare inherited metabolic disorders characterized by defects in the function of specific enzymes responsible for breaking down substrates within cellular organelles (lysosomes) essential for the processing of macromolecules. Undigested substrate accumulates within lysosomes, leading to cellular dysfunction, tissue damage, and clinical manifestations. Clinical features vary depending on the degree and type of enzyme deficiency, the type and extent of substrate accumulated, and the tissues affected.
View Article and Find Full Text PDFJ Relig Health
January 2025
Faculty of Health Sciences and Nursing, Center for Interdisciplinary Research in Health, Universidade Católica Portuguesa, Palma de Cima, 1649-023, Lisbon, Portugal.
The study of spirituality in nursing education has become an emerging academic field, making it important to understand its evolution using bibliometric indicators. To achieve this, a search was conducted on July 8, 2024, using the Web of Science and Scopus databases. Titles and abstracts were screened in Rayyan, and data analysis was performed using Bibliometrix and Biblioshiny in the R language.
View Article and Find Full Text PDFIntensive Care Med Exp
January 2025
Freie Universität Berlin and Humboldt-Universität Zu Berlin, Department of Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
Purpose: CytoSorb® (CS) adsorbent is a hemoadsorption filter for extracorporeal blood purification often integrated into continuous kidney replacement therapy (CKRT). It is primarily used in critically ill patients with sepsis and related conditions, including cytokine storms and systemic inflammatory responses. Up to now, there is no evidence nor recommendation for the use of CS filters in sepsis (22).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!